Epic Sciences Revenue and Competitors

Location

$152.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Epic Sciences's estimated annual revenue is currently $18.8M per year.(i)
  • 0
  • Epic Sciences's total funding is $152.5M.

Employee Data

    00

Epic Sciences's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
General Counsel, Chief Compliance Officer, and EVP, Corporate DevelopmentReveal Email/Phone
3
CTOReveal Email/Phone
4
VP Finance and AdministrationReveal Email/Phone
5
SVP, Laboratory OperationsReveal Email/Phone
6
Director, Clinical Research OperationsReveal Email/Phone
7
Director Customer SuccessReveal Email/Phone
8
Director, Data SciencesReveal Email/Phone
9
Director, Manufacturing and LogisticsReveal Email/Phone
10
Director, PMOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Epic Sciences?

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic?s mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient?s journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Our technology helps match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen at every clinical decision point. Today, we partner with leading pharmaceutical companies and major cancer centers around the world. Epic?s goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians real-time information to guide treatment choices. For more information please contact us at info@epicsciences.com

keywords:N/A

$152.5M

Total Funding

N/A

Number of Employees

$18.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Epic Sciences News

2022-03-22 - Epic in the headlines: 10 March updates

The University of Arkansas for Medical Sciences used Epic's EHR system to train physicians using synthetic data. Epic added AI symptom...

2022-03-22 - Defining Clinical Utility of Germline Indicators of Toxicity Risk: A ...

Consulting or Advisory Role: Cepheid, Freenome, Epic Sciences, Cellworks, BioVica, Oncocyte, Turnstone Bio, Predictus Biosciences,...

2022-03-22 - Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer

He also has held various commercial executive roles at Epic Sciences Inc., Metabolon Inc., Abaxis Inc. (Zoetis Inc.), and Cytyc Corp...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M0N/A$168.6M
#2
$8.4M0N/AN/A
#3
$11.7M0N/A$4.4M
#4
$36.4M0N/A$778M
#5
$1.7M0N/AN/A